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27th Annual Canine Symposium
The 27th Annual Canine Sym-posium took place on January
25 at VHUP. The event, held in
honor of Dr. M. Josephine
Deubler, who organized the first
Canine Symposium in 1970, fo-
cused on canine genetic diseases.
Genetic Disease
Dr. Donald F. Patterson, professor of
medical genetics at the School, opened
the seminar by displaying the cover of a
recent issue of Time magazine that inves-
tigated dog breeding practices. He called
the article — which asserted that pure-
bred dogs are riddled with disease be-
cause of irresponsible breeding methods
— an unjustified indictment of the dog
breeding community. He said the prob-
lems can be more accurately assessed
only by understanding the complex
mechanisms of genetic diseases.
Genetic diseases are caused by muta-
tions — or alterations in the structure and
function of genes, rather than by the envi-
ronment. Genes are comprised of DNA
sequences. These sequences serve as tem-
plates for messenger RNA, which directs
protein synthesis. Hence, genetic defects
ultimately result in the manufacture of ab-
normal proteins — perhaps enzymes, bio-
logical receptors or structural proteins
comprising cell membranes and connec-
tive tissues. Genes, which direct growth,
development and function of the body’s
organs throughout life, number some
50,000 in every mammal. The genome of
dogs differs from that of humans by only
about 10-20 percent of the nucleotides.
Thus, explained Dr. Patterson, “You can
expect that all mammals will generally
have the same number and kinds of ge-
netic diseases.”
Yet while some 5,000 genetic disor-
ders have been mapped out in humans, a
mere 350-or-so have been documented in
the dog. Owing to a series of major scien-
tific breakthroughs, this represents a loga-
rithmic increase from the number of
canine inherited diseases described in the
1930’s, when just a handful of such
anomalies was recognized. “Because of
the tremendous progress in the develop-
ment of vaccines, antibiotics and nutri-
tious diets,” said Dr. Patterson, “we’ve
gotten rid of a lot of the non-genetic prob-
lems and been able to concentrate our ef-
forts on genetic diseases.”
Our expanded understanding of ge-
netic defects, which, in recent years, has
led to the identification of about five to
ten canine genetic diseases annually, can
also be attributed to the development of
modern diagnostic methods. A large per-
centage of genetic maladies documented
in the dog thus far are orthopedic, ocular
or neurological, perhaps because of the
more obvious clinical signs they produce.
But researchers are now striking major
advancements in those genetic abnormali-
ties that cause more subtle signs and chal-
lenge diagnostic methods.
One such case is vitamin B12 (cobal-
amin) deficiency, which was first de-
scribed by a veterinary medical geneticist
at the School. The first known affected
dogs presented at a few months of age.
They showed general signs of failure to
thrive, including anorexia, anemia and
weakness, and were small in relation to
their litter mates. Using paper chromatog-
raphy, researchers identified
methylmalonic acid in the urine. The
presence of this abnormal metabolite sig-
nals a defect in either an enzyme involved
in the metabolism of organic acids or an
enzyme cofactor. The problem in this case
was found to be a lack of cofactor (vita-
min B12) receptors in the ileum, where
they are inserted following genetic trans-
lation. Unlike many genetic diseases, co-
balamin defects have an effective therapy
— parenteral administration of vitamin
B12.
Vitamin B12 deficiency is an autoso-
mal recessive disease, as are most under-
stood genetic disorders of purebred dogs.
In his retort to the Time magazine story,
Dr. Patterson said that inbreeding — the
mating of individuals that share common
ancestry, does not cause genetic disease.
Rather, he said, inbreeding can increase
the chance of a disease-causing recessive
mutant gene being transmitted in double
dose to the offspring.
In order to eliminate recessive
diseases, Dr. Patterson explained, we
must be able to recognize affected indi-
viduals and refrain from breeding them.
But, he added, “That’s not enough, be-
cause most of the genes that cause these
recessive disorders are in the population
in carriers. We don’t know that an animal
is a carrier unless it’s bred to another car-
rier and produces affected individuals.”
If, for example, the frequency of a de-
fect were four percent and the affected in-
dividuals were removed from the
breeding population, it would take over
ten generations to reduce the frequency of
disease to one percent. But if both the car-
riers and those affected were extracted
from the breeding population, the disease
would be eliminated in one generation.
So the key to abolishing canine genetic
diseases, Dr. Patterson said, is to identify
carrier dogs.
To this end, the School has undertaken
four major initiatives: research in bio-
chemical and molecular abnormalities in-
volved in specific genetic diseases;
development of carrier tests based on de-
tection of either abnormal gene products
or structural changes in the DNA of mu-
tant genes; operation of a genetics/pediat-
rics clinic at VHUP, where breeders and
owners of animals with known or sus-
pected genetic diseases can seek diagnos-
tic services and genetic counseling; and
development of a compendium of genetic
diseases, to be published in book and
software forms within the next year.
Screening for
Inherited Diseases
Dr. Urs Giger, professor of medicine
and medical genetics, discussed screening
for inherited disease. In contrast to the
common dominant inheritance of diseases
in humans, most hereditary diseases in
dogs are recessively inherited. In autoso-
mal recessive inheritance both asymptom-
atic parents may contribute an abnormal
(mutant) gene to an offspring which will
then have two mutant genes (homozy-
gous) and is, therefore, affected. Most
metabolic and eye disorders are inherited
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by an autosomal recessive trait. In x-
linked recessive disorders, the asymptom-
atic dam will pass on one of her
x-chromosomes to the male and female
offspring, however, if the male inherits
the x-chromosome containing a mutant
gene, the males will be affected with e.g.,
hemophilia or muscular dystrophy. Fi-
nally, with complex traits such as hip dys-
plasia and certain cancers, environmental
factors also play a role in the expression
of the disease. Thus, in order to control
hereditary diseases in dogs, it will be im-
portant not only to identify affected dogs,
but also carriers which carry one copy of
a mutant gene, but have no clinical signs.
Veterinarians and breeders have sev-
eral tools to identify diseased animals.
Since many genetic diseases are breed-
specific, the signalment of an animal may
suggest a disorder known to occur in that
breed. Most diseases are associated with
characteristic clinical signs which occur
at a typical age. Neonates and juvenile
dogs are more likely to suffer from a ge-
netic disorder (this is known as the fading
puppy syndrome), although a few genetic
diseases may only cause signs in adult-
hood. Failure to thrive, growth retarda-
tion, and malformations are commonly
seen, and neurologic and ophthalmologic
signs may also be evident. In contrast to
malnutrition, infections, and intoxica-
tions, the clinical manifestations are usu-
ally chronic progressive, however, genetic
predisposition to infection and bleeding
may be associated with intermittent signs.
An easy way to recognize an unthrifty
puppy early, is to regularly weigh puppies
and compare with littermates. Routine
blood and urine tests as well as imaging
studies such as radiographs, ultrasound
and ophthalmoscopy rule out many ac-
quired diseases and may further suggest
an inherited disorder.
The Veterinary School’s Section of
Medical Genetics has developed and es-
tablished screening tests for many meta-
bolic or hematologic hereditary disorders
(see Josephine Deubler Genetic Disease
Testing Laboratory). Since inborn errors
lead to dysfunction of a biological path-
way they can be identified by product de-
ficiency and accumulation of substrates
or alternative substances. A small urine
sample is often more helpful for these
screening tests than serum or other speci-
mens. For instance, specific sugars are
found in urine of puppies with certain
skeletal and neurological abnormalities
known as mucopolysaccharidoses. Cys-
tine, a poorly soluble building block of
proteins, accumulates in dogs with cysti-
nuria and can lead to kidney and bladder
calculi, resulting in inability to urinate, an
emergency situation.
We are aiming to not only identify the
failing biological pathway in affected ani-
mals, but to determine the responsible
protein that is defective. In fact, various
gene defects may result in the failure of
the same biologic function, thus, identifi-
cation at the protein or DNA level is im-
portant to reach a specific diagnosis. The
best examples are deficiencies of enzyme
activities, inability of a receptor to bind,
or a lack of transporters to move sub-
stances across a membrane. Such tests are
now available for several dozens of ge-
netic defects in dogs.
These specific functional and immu-
nologic tests are not only useful to con-
firm a specific defect in an affected dog,
but also to identify carriers. Carriers or
heterozygotes, who carry one normal
and one mutant gene, are asymptomatic,
but can pass on the mutant gene to their
offspring. Thus, in order to produce
healthy dogs it is pivotal to recognize
carriers and eliminate them from breed-
ing. Although parents and offspring of
affected dogs are obligate carriers, for
others laboratory tests are needed to
know whether they are carriers or nor-
mal. Instead of having the normal 100%
specific enzyme function, carriers have
intermediate activity or amount of ap-
proximately 40-60% compared to con-
trols. Although very helpful, these
carrier tests are time consuming and
technically demanding, and require spe-
cial specimen submission. Because of
these difficulties, these carrier tests are
not completely accurate. Therefore, it is
exciting that for some of these inherited
disorders, the molecular genetic defect
has been identified which will simplify
testing in the near future for many he-
reditary disorders in dogs.
Molecular
Genetic Tests
Biochemical tests are useful in diag-
nosing specific inherited diseases. How-
ever, said Dr. Paula Henthorn, associate
professor of medical genetics at the
School, they have limitations. For ex-
ample, they occasionally fail to distin-
guish carriers from normal dogs.
“Sometimes what we detect in the lab
doesn’t really represent what’s going on
in the animal,” Dr. Henthorn explained.
The future generation of genetic tests
will be based on DNA analysis. DNA, or
deoxyribonucleic acid, is a double strand
comprised of billions of the four nucle-
otide bases. “If you thought of each base
pair as a bead on a string, that string
would stretch from here to San Fran-
cisco,” said Dr. Henthorn.
Of even greater consequence, a substi-
tution, addition or deletion in just one of
the six trillion base pairs in the genome
can dramatically alter the protein a gene
encodes. Such minute modifications can
have deleterious consequences. For ex-
ample, phosphofructokinase (PFK) defi-
ciency, which leads to hemolytic anemia
and exercise intolerance in the English
springer spaniel, results from a single
base substitution. X-linked severe com-
bined immunodeficiency (XSCID), which
is lethal in young dogs, is caused by a de-
letion of only four nucleotides.
Molecular genetic testing can be per-
formed in puppies shortly after birth. In
testing for a particular disorder, one must
know what sequence mutation to look for.
DNA can be isolated very non-invasively,
perhaps in a drop of blood, hair follicle,
frozen semen, or cheek cells. The poly-
merase chain reaction (PCR) is used to
amplify selected DNA segments up to bil-
lions-fold so they can be examined. Re-
striction enzymes are then employed to
cut the fragments of interest. These frag-
ments are then run on gel electrophoresis,
which separates them according to size
and thereby distinguishes normal from
abnormal fragments.
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Both PFK deficiency and XSCID,
which are caused by mutations that create
new restriction sites, can be diagnosed in
this manner. But detecting the genetic ab-
erration in a single dog is only half of the
battle, Dr. Henthorn said.
“Once we’ve looked at an individual
animal, we have to analyze the results in
the larger context of what we know about
the breed or the pedigree.”
Over 244 dogs were screened for PFK
deficiency between 1993 and 1995. These
mass diagnostic efforts shed light on the
occurrence of the mutation throughout the
springer spaniel breed. Likewise, the rec-
ognition of a single case of XSCID led to
broad testing of the affected dog’s pedi-
gree. Researchers at the School traced the
defect back to the dog’s grandmother,
flagged female carriers and advised own-
ers on modifying their breeding strate-
gies.
“These tests involve genetic counsel-
ing to understand the frequency of the
marker you’re looking at and the inherit-
ance in the pedigree,” Dr. Henthorn ex-
plained.
These sophisticated diagnostics are
presently only available for heritable dis-
eases caused by single-gene defects. But
in this rapidly burgeoning field, Dr.
Henthorn added, tests for multiple-gene
disorders, such as hip dysplasia, will be
developed in the years to come.
Hereditary Diseases
Affecting Immune
System
Primary immune deficiencies are ge-
netic defects that compromise the im-
mune response and thereby render
affected individuals highly susceptible to
infection. Dr. Peter J. Felsburg, professor
of immunology at the School and chair-
man of the department of clinical studies
at VHUP, explained the etiologies of sev-
eral inherited immune disorders and dis-
cussed diagnostic methods.
White blood cells, or leukocytes, are
the work horses of the immune system.
Their constituents, including B and T lym-
phocytes, monocytes and neutrophils,
course through the peripheral circulation.
Leukocytes develop from pluripotent stem
cells and are renewed throughout life.
The major function of B lymphocytes
is to produce antibodies ( humoral immu-
nity) that confer protection against bacte-
rial infection. T lymphocytes, which
direct cell-mediated immunity, fend off
intracellular invaders, such as fungi, pro-
tozoa and viruses; a subset of T lympho-
cytes, helper T cells, regulate and
enhance humoral immunity. Monocytes
and neutrophils, the “garbage collectors”
of the immune system, phagocytize for-
eign invaders. Complement - enzymatic
proteins in the serum, combines with the
antigen-antibody complex to stimulate ly-
sis of potentially pathogenic antigen. A
flaw in any of these immune components
can cause an immunodeficiency syn-
drome, Dr. Felsburg explained.
“Where the genetic defect is in the de-
velopment of the immune system deter-
mines how severe the immune deficiency
is.”
Some 50 heritable immune deficien-
cies have been identified in humans. In
the dog, only four or five have been docu-
mented. “These same 50 disorders should
also be seen in the dog, and in higher in-
cidence because of inbreeding,” said Dr.
Felsburg.
The clinical features of immune in-
competence in the dog include recurrent,
chronic infections that are refractory to
treatment; chronic diarrhea; growth retar-
dation; and adverse reactions to modified
live vaccines.
Several simple tests are used to diag-
nose canine immune deficiencies. They
include quantification of antibodies or
complement, measurement of B- and T-
lymphocyte maturity through analysis of
cell surface markers, and challenge assays
to assess the competence of both the T
lymphocytes (lymphocyte transformation
test [LTT]) and the phagocytic system.
Among the significant primary im-
mune deficiencies that have been reported
in the dog are XSCID, selective IgA defi-
ciency and leukocyte adhesion deficiency
(LAD). In XSCID, both humoral and cell-
mediated immunity are compromised. Af-
flicted dogs experience chronic infections
that typically begin at a few months of
age. These infections, usually bacterial,
are generally unresponsive to antibiotic
therapy. Affected dogs are smaller than
their litter mates and exhibit marked fail-
ure to thrive.
Interleukin-2, or IL-2, stimulates T
lymphocytes to proliferate in normal
dogs. Dogs with XSCID lack IL-2 cell
surface receptors. Likewise, they do not
respond to IL-2 therapy. Two tests are
used to diagnose XSCID. With the first, T
cells are stimulated with antigen and IL-2
is added. T cell response is absent in af-
fected dogs. The second test uses antibod-
ies against IL-2 receptors to determine
whether these receptors are present. Be-
cause XSCID is a recessive disease, carri-
ers are not clinically affected. In hopes of
purging the breeding population of this
deadly gene, researchers at the School
have developed carrier tests for XSCID.
Selective IgA deficiency, which leads
to less severe recurrent infections, occurs
quite commonly in dogs. It can be diag-
nosed with LTT or by measurement of the
serum IgA concentration, which is pro-
foundly depressed in affected dogs.
LAD is caused by defective integrins,
proteins that enable phagocytes to bind to
microorganisms. Signs of LAD, which
occur at a few weeks of age, include re-
current pyogenic infections and poor
wound healing. LAD is often diagnosed
using flow cytometry to discern the pres-
ence of normal adhesion molecules.
Once an immunodeficiency has been
identified using one of myriad screening
tests, Dr. Felsburg said, more sophisti-
cated assays can be employed to locate
where the defect is. Researchers are
working to pinpoint the genes responsible
for these problems, and then develop car-
rier tests.
Heritable Renal
Diseases
A variety of serious kidney disorders
are encoded by genes. Likewise, they
have breed predispositions, said Dr.
27th Annual Canine Symposium
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Meryl Littman, associate professor of
Medicine at VHUP.
The kidney plays several homeostatic
roles. It filters the blood through its glom-
eruli — small, convoluted tufts of capil-
laries, and excretes toxic waste products.
The renal tubules resorb substances from
the glomerular filtrate — such as amino
acids, sugars, water and electrolytes, in
amounts necessary to maintain hydration,
acid-base balance, blood pressure and
other normal parameters. Also, the kidney
manufactures important vitamins and hor-
mones.
As a homeostatic organ, the kidney is
so efficient that it can serve all of the
body’s functions with just a portion of its
nephrons, or functional renal units. The
dog, for example, can lose one of its two
kidneys and remain healthy. With a 67
percent loss of renal mass, it might ex-
hibit polyuria/polydipsia (pu/pd), but se-
rum measures of renal function, such as
creatinine and blood urea nitrogen
(BUN), are not affected. In fact, renal
failure does not typically occur until
about three-quarters of the renal paren-
chyma is destroyed.
Clinical signs of renal failure include
pu/pd, dehydration, anorexia, vomiting,
weight loss, anemia, hypertension and as-
cites. Laboratory tests typically show el-
evated BUN, creatinine and phosphorus.
Several inherited renal defects — renal
dysplasia, glomerular diseases, tubular
diseases and structural abnormalities —
can lead to renal failure. Yet when they
occur, these problems should not be as-
sumed to be genetic; infectious and meta-
bolic mechanisms, for example, may be
the cause. In assessing their etiology, it is
important to survey the affected dog’s
pedigree and consider whether a breed
predisposition exists for the disorder.
Renal dysplasia is a congenital or neo-
natal disorder that results in maldevelop-
ment of the kidneys. The renal reserve
can be severely compromised by renal
dysmaturity, predisposing the dog to pro-
gressive renal failure. Renal dysplasia is
thought to be familial in the Lhasa apso,
Shih Tzu, miniature schnauzer, Doberman
pinscher, chow chow, soft coated wheaten
terrier, golden retriever, and standard
poodle breeds.
Clinical signs of renal dysplasia include
poor growth, pu/pd, cachexia and “rubber
jaw.” Blood work reveals elevated BUN
and creatinine; urinalysis shows low urine
specific gravity and possibly signs of uri-
nary tract infection; and on radiographs,
the kidneys appear small. A diagnosis can
also be rendered by kidney biopsy, which
may reveal maldeveloped fetal glomeruli
and mesenchyme, and renal atrophy. Renal
dysplasia is thought to be an autosomal re-
cessive trait, but no carrier tests have yet
been developed.
Unlike renal dysplasia, which usually
presents in young dogs, glomerulopathies
may emerge clinically at any age. They
are characterized by protein-losing nephr-
opathy, which leads to edema/ascites, hy-
pertension and thromboembolism.
Affected dogs have elevated BUN and se-
rum creatinine, low serum albumin, and
proteinuria. Glomerulonephritis and amy-
loidosis may be evident on biopsy. Like
renal dysplasia, glomerulopathies seem to
gravitate toward certain breeds of dogs,
including beagles, Basenjis, Samoyeds,
Labrador and golden retrievers, soft
coated wheaten terriers, Bernese moun-
tain dogs, Dobermans, bullmastiffs, bull
terriers, English cocker spaniels, Rott-
weilers, and Sharpeis. Likewise, Dr.
Littman cautioned, the pathogenesis of
these disorders may vary from breed to
breed.
“They may look the same on paper but
there may be different genetic reasons for
the problem,” she said.
Certain dog breeds are also predis-
posed to tubular diseases and structural
anomalies. Telangiectasia occurs in some
Pembroke Welsh corgi dogs. The Siberian
husky appears prone to ectopic ureter and
subsequent hydronephrosis.
“I think you can see how complex
these renal disorders are and the variety
of diseases that might present,” said Dr.
Littman.
The genetic defects inherent in most
inherited kidney disorders have not yet
been identified, she added. But once these
modes of inheritance are worked out, spe-
cial breeding strategies may be devised to
reduce the occurrence of these often-de-
bilitating maladies.
Genetic Basis of
Hip Dysplasia
Sound imaging techniques for diag-
nosing the presence of hip dysplasia are
currently available. By incorporating the
results of these tests into breeding pro-
grams, said Dr. Gail K. Smith, professor
of surgery at the School and chief of the
section of surgery at VHUP, we can select
for better hips in future generations of
dogs.
Hip dysplasia is the most common
heritable orthopedic disease of the dog.
Due to a misshapen femoral head (ball) or
shallow acetabulum (socket), the ball-
and-socket hip joint does not form a tight
union in dysplastic dogs. Consequently,
these individuals have lax, or loose-fit-
ting, hips. Joint laxity may, depending
upon the severity, over time lead to de-
generative joint disease (DJD), or
arthritis.
Hip dysplasia in the dog was first de-
scribed in the 1930s. After decades of re-
search on the disorder, why are there still
so many dogs walking around on bad
hips? For one thing, little is known about
the genetic scheme and molecular pat-
terns of hip dysplasia. What is under-
stood, however, is that hip dysplasia
arises from a complex form of inherit-
ance. Its expression is polygenic and mul-
tifactorial; in other words, many genes, as
well as environmental factors, influence
its development.
The other reason hip dysplasia is ubiq-
uitous is that dysplastic dogs have not
been kept out of the breeding pool be-
cause, until recently, their disorder was
not accurately diagnosed. In 1983, Dr.
Smith developed the PennHIP® program,
which utilizes a highly reliable method
for diagnosing hip dysplasia. By the
PennHIP® method, radiographs are taken
when the dog’s hips are in the neutral
(standing) position, which allows maxi-
mum laxity. (The traditional position used
for evaluating hip status was legs fully
extended.) The femoral heads are then
manually pushed laterally out of the ac-
etabula as far as they will easily go. A
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distraction index (DI), which measures
the distance the heads can be pushed out
of the joint, is then calculated. The DI is
numbered 0 (no laxity) through 1 (com-
plete laxity). A DI of .75, for example, in-
dicates that the hips can be translated 75
percent from the congruent position.
But, said Dr. Smith, “The fact that we
can measure laxity is meaningless unless
we can link it to future development of
osteoarthritis.”
Ongoing research indicates that hip
laxity is the most important factor in pre-
dicting DJD. Tighter hips are better hips,
Dr. Smith said. But, he added, arthritis
susceptibility is also highly breed depen-
dent. In other words, different breeds of
dogs have different degrees of tolerance
of laxity in their hip joints; for example,
German shepherd dogs are more likely to
develop arthritis, given the same amount
of laxity, than are Rottweilers. Environ-
mental factors can also dramatically in-
fluence the expression of arthritis in an
arthritis-prone dog.
Studies show that an individual’s DI is
consistent over time. Dogs have essen-
tially the same amount of laxity as pup-
pies as they do years later. Thus, hip
laxity can be accurately determined as
early as four months of age, well before a
dog is ready to be bred. This is important
because hip dysplasia is a highly heritable
disorder.
Heritability is a measure of the total
variability in phenotypic traits attribut-
able to genetic differences among indi-
viduals. Hip dysplasia has a high degree
of heritability, according to the results of
an extensive, soon-to-be-published study
Dr. Smith conducted that showed dysplas-
tic dogs parent dysplastic puppies. Breed-
ers can place heritability in their corner
by applying selection pressure to their
breeding populations, Dr. Smith ex-
plained. The more selection pressure they
apply, the greater the change in the trait
from one generation to the next. Key to
this strategy is accurate identification of
healthy individuals.
“We must rely on diagnostic tests to
help us cleanse this gene pool of the bad
genes,” Dr. Smith said.
Breeding the extremes for a particular
trait will attenuate of the expression of
that trait rather rapidly. In a study con-
ducted in the mid ‘80s, test matings of an
isolated population were performed. After
evaluating the hips of 71 German Shep-
herd dogs, a male and a female were
identified with DIs similar to those of rac-
ing greyhounds, 0.21 and 0.19 respec-
tively. These two dogs were mated and
the resultant litter had a mean DI of .27,
which represented a 60 percent shift from
the original breeding population. Succes-
sive breedings were monitored for several
years thereafter. By 1991, two genera-
tions later, 80 percent of the kennel’s out-
put had DIs below .3.
Such success can be replicated in other
populations of dogs. By utilizing PennHIP’s
services to obtain accurate ratings of hip
laxity, breeders might then design breeding
protocols that select from the tight half of
the breed in each generation interval. Thus,
they can effect a moderate rate of genetic
change with each consecutive generation
without losing desirable traits or increasing
the likelihood of introducing new undesir-
able characteristics.
Hereditary
Eye Diseases
Canine inherited retinal degeneration
causes characteristic optic changes that
are consistent among various breeds. But
what appears to be a single disorder, said
Dr. Gregory M. Acland, adjunct associate
professor of ophthalmology in medical
genetics at the School, is not.
“There are lots of clues that the dis-
ease may be different intrinsically from
breed to breed,” he said.
Progressive retinal atrophy (PRA) is a
gradual, blinding disorder. Affected dogs
develop degenerative changes in the
retina with age. Early in the disease, they
become night blind. As more of their pho-
toreceptors degrade over time, these dogs
lose their day vision as well. The pupils
of their eyes become increasingly dilated
and prone to developing cataracts.
Upon indirect ophthalmoscopic exami-
nation, several pathologic changes are evi-
dent: hyperreflectivity of the tapetal
fundus; reduced diameter and branching
pattern of retinal blood vessels; and atro-
phy of the optic nerve head. Diagnosis can
be confirmed by either electroretinography
or retinal morphological examination.
The major indicator that PRA repre-
sents several different pathogenetic
mechanisms is the breed-related differ-
ence in the age of onset and rate of pro-
gression of the disease. Certain breeds,
such as the collie, Irish setter, Norwegian
elkhound and miniature schnauzer, have
early-onset forms of retinal degeneration.
In these breeds, the disease results from
abnormal or arrested development of the
photoreceptors and affects dogs early in
life. In other breeds, such as the miniature
poodle, Labrador retriever and cocker
spaniel, PRA has much later onset.
Studies were conducted to determine
whether all of the early-onset forms —
though they occur in several dog breeds,
represent the same molecular disease pat-
tern. In one trial, the test mating of an af-
fected Irish setter to an affected elkhound
produced a litter of unaffected puppies.
The phenotypically-normal puppies (car-
riers of both disorders) were then bred to
affected collies. This second litter con-
sisted of all normal puppies. Given that
PRA is an autosomal recessive trait in all
breeds but the Siberian husky — in which
it is x-linked recessive, it is apparent that
different genetic forms of PRA occur in
the three breeds.
Likewise, test matings were conducted
between dogs of several breeds that de-
velop late-onset PRA. The results of these
matings pointed toward a single gene at
work. Thus, the late-onset forms of PRA
result from mutations in the same gene.
Mutations in a variety of
phototransduction genes have been impli-
cated in retinitis pigmentosa, the equiva-
lent disease in people to PRA in dogs, and
in retinal degenerations in mice. These in-
clude for example, mutations in the genes
for rhodopsin — the photosensitive pig-
ment in rods, and for the
phototransduction enzyme phosphodi-
esterase (PDE). Defects in the PDE-beta
gene, for example, have been found to
cause PRA in dogs and humans; PDE-al-
pha mutations cause retinitis pigmentosa
27th Annual Canine Symposium
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in humans; and PDE-gamma gene knock-
outs produce retinal degeneration in mice.
But confounding these data is the fact
that anomalies in a single gene such as
RDS/peripheral can continue to lead to a
variety of disorders with different pat-
terns of inheritance. In fact, individuals
from the same pedigree with the same
mutation may exhibit different disorders
phenotypically.
“The pathogenesis of these diseases is
not quite as clear as we had hoped,” said Dr.
Acland. Considerable effort has been ex-
pended in evaluating these genes as candi-
dates for the mutant locus in several forms
of PRA, and a PDE-beta mutation has been
identified as the cause of PRA in Irish set-
ters. Despite this success, however, the end
result of all other studies to date has been to
prove that PRA is not caused by mutations
in these phototransduction genes.
In order to delineate these disease
mechanisms, researchers are working to
pinpoint the genes responsible for PRA in
specific breeds. A reliable DNA test for
the presence or absence of rod-cone dys-
plasia 1 (rcd1), which causes early-onset
PRA in Irish setters, already exists. But
the molecular bases of the other early-on-
set forms, as well as late-onset progres-
sive rod-cone degeneration (prcd), are
still being mapped out.
Research on the molecular foundation
of retinal degeneration is now turning to-
ward mapping the genes and loci respon-
sible for disease, as well as developing
marker tests to spot defective alleles and
trace their patterns of inheritance. These
investigations have broad implications,
Dr. Acland said.
“Progressive retinal atrophy is really a
paradigm for all the hereditary eye diseases.”
...and perhaps for other genetic dis-
eases as well.
Treatment of
Genetic Diseases
Even the best detection systems to di-
agnose and prevent genetic diseases don’t
alleviate the need for therapy to treat dis-
orders produced by new mutations, said
Dr. Mark E. Haskins, professor of pathol-
ogy and medical genetics at the School.
“It’s possible to treat these diseases by
getting around the genetic problems that
exist,” he said.
Several therapeutic approaches exist.
The simplest of these is direct, pheno-
typic treatment. These include reconstruc-
tive surgery for structural malformations,
such as polydactylism, hip dysplasia, and
patent ductus arteriosus.
“But this type of treatment is dissatis-
fying in some respects,” Dr. Haskins said.
The reason, he explained, is that it
doesn’t really get to the core of the prob-
lem. Using NIH funding, Dr. Haskins is
testing a variety of treatment modalities
for genetic defects.
For metabolic problems, there are
therapies that work at the biochemical
level. They might limit the availability of
a compound in the diet that can become
toxic due to genetic deficiencies in pro-
cessing, remove the toxic product made
by the body, or provide a missing non-
protein product, such as vitamin B12.
For disease caused by dysfunctional or
deficient proteins, it’s possible to either
enhance the activity of the defective en-
zyme or provide the normal gene product,
such as insulin or enzymes. For example,
a dog with exocrine pancreatic insuffi-
ciency has inadequate secretion of diges-
tive enzymes. These enzymes can be
therapeutically replaced in the food,
thereby eradicating the clinical manifesta-
tions of maldigestion and malabsorption.
For a dog with von Willebrand’s disease,
which is characterized by the deficiency
of clotting factors that leads to prolonged
bleeding, the missing coagulation pro-
teins can be restored by plasma infusion.
Enzyme replacement can also be used
for lysosomal storage disorders. These
diseases encompass a variety of rare, ge-
netic (mostly autosomal recessive) de-
fects described in several breeds,
including the beagle, German shorthaired
pointer and wirehaired dachshund. Lysos-
omes - small intracellular organelles that
contain hydrolytic enzymes — are the
“little garbage disposals of cells,” Dr.
Haskins said. Deficiency of any of these
enzymes can lead to accumulation of me-
tabolites inside the lysosome. Dr. Haskins
likened the lysosomes that become
grossly enlarged in these storage disor-
ders to ping pong balls that grow to the
size of basketballs.
“We’re trying to understand why tak-
ing a cell and filling it with basketballs as
opposed to ping pong balls makes these
animals look the way they do, and then
treat them,” Dr. Haskins explained.
Animals with one group of these disor-
ders, mucopolysaccharidosis, exhibit
stunted growth, facial dysmorphia, cor-
neal clouding, organomegaly, and neuro-
logical and skeletal abnormalities. Human
children with mucopolysaccharidosis are
mentally retarded and typically die by the
age of ten.
Lysosomal storage diseases are caused
by defects in the genes coding for lysoso-
mal enzymes. Replacement enzymes can
be produced in vitro by genetically-engi-
neered cells and then infused into affected
individuals. This has been shown to be
successful in children, but may not work
well in the dog because of an immune re-
sponse to the new enzymes and also must
be given IV weekly for the life of the dog.
Heterologous transfer through bone
marrow transplants, given intravenously
from normal to affected siblings, has been
effective in the dog. In this method —
known as “cross correction” — Dr.
Haskins said, “We give normal cells as
enzyme factories. They make the en-
zymes, which are then delivered to the
rest of the body. The hope is that these
enzymes travel to the bone, cornea, heart
valves and all the other affected organs.”
Gene transfer can also be a permanent
fix to the problems caused by mutant
genes. It involves cloning normal copies
of a defective gene and then delivering
them, via retrovirus vectors, to the
patient’s own abnormal cells. Still in the
experimental stages, this method, which
also utilizes bone marrow transplantation,
has several hurdles to overcome before it
can be used clinically.
These innovative therapies incorporate
different approaches ultimately designed
to alleviate disease in affected dogs. Yet
with years of experimentation ahead, they
are still at the bottom of the refinement
curve.
—Joan Capuzzi, V’98
